Cancer Biomarkers Market for TMB, MSI / MMR and TILs is Projected to be Worth Over USD 860 Million by 2030, Growing at an Annualized Rate of 18.3%, Claims Roots Analysis
Advertisement
Advances in biotechnology and genome analysis have enabled the identification of several novel cancer biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, and to facilitate therapy related decisions
